Ocular Therapeutix Inc (NASDAQ:OCUL)

4.15
Delayed Data
As of Sep 30
 -0.98 / -19.10%
Today’s Change
2.91
Today|||52-Week Range
12.50
-40.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues498.0K504.0K492.0K650.0K
 
 
 
 
 
Cost of Goods Sold115.0K117.0K128.0K552.0K
 
 
 
 
 
Depreciation And Amortization573.0K582.0K776.0K598.0K
 
 
 
 
 
 
Operating ExpensesGross Income-190.0K-195.0K-412.0K-500.0K
 
 
 
 
 
General Expenses14.6M17.1M19.2M21.1M
 
 
 
 
 
Research And Development9.7M10.3M11.3M9.4M
 
 
 
 
 
Total Operating Expenses15.3M17.8M20.2M22.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.8M-17.3M-19.7M-21.6M
 
 
 
 
 
Extraordinary Credit0.000.003.2M0.00
 
 
Extraordinary Charge0.000.00---1.6M
 
 
Interest Expense On Debt424.0K374.0K1.0M1.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.0M-17.4M-17.1M-24.5M
 
 
 
 
 
Net Income-15.0M-17.4M-17.1M-24.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.0M41.1M42.3M42.9M
 
 
 
 
 
Shares To Calculate EPS Diluted39.0M41.1M44.2M42.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$0.42-$0.45-$0.57
 
 
 
 
 
EPS Diluted-$0.38-$0.42-$0.45-$0.57